医学
肝移植
无症状的
肝内胆管癌
肝病
新辅助治疗
药物治疗
疾病
移植
内科学
重症监护医学
肿瘤科
普通外科
外科
癌症
乳腺癌
作者
Olanrewaju Eletta,Guergana G. Panayotova,Keri E. Lunsford
标识
DOI:10.1016/j.suc.2023.07.006
摘要
Intrahepatic cholangiocarcinoma (iCCA) tends to be asymptomatic until late stages, leading most of the patients to present at advanced stages of the disease. A combination of medical and surgical therapy is crucial for patient management. Historically, poor outcomes resulted in liver transplantation being formally contraindicated for patients with iCCA; however, recent advances in patient selection and neoadjuvant therapy have resulted in a paradigm shift in liver transplant oncology. As a result, the feasibility of liver transplantation for iCCA is being reevaluated by several centers as a therapeutic alternative for select patients with locally advanced unresectable disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI